{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":2,"sponsored":0,"items":[{"id":"n_jicnankynwl46ghy6ulq","seq":828787,"kind":"article","title":"EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis","url":"https://www.finanznachrichten.de/nachrichten-2026-09/69711730-eadv-2026-galderma-s-new-data-show-sustained-improvements-with-nemluvio-nemolizumab-for-up-to-three-years-in-patients-with-moderate-to-severe-atopi-004.htm","published":"2026-09-30T05:22:42Z","seen":"2026-09-30T05:22:42Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","health","politics","education"],"authors":["Business Wire"],"entities":[{"id":"Q581008","name":"Galderma","type":"org"},{"id":"Q30314619","name":"nemolizumab","type":"other"},{"id":"Q268667","name":"atopic dermatitis","type":"other"}],"story":"st_jicnankynwl46ghy6ulq","category":"health","category_p":0.61,"sentiment":"positive","tone":0.1,"political":0.02},{"id":"n_t6pdyzs5c5s4gs5vuiha","seq":844261,"kind":"article","title":"EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis","url":"https://www.thewhig.com/press-releases/business-wire/eadv-2026-galdermas-new-data-show-sustained-improvements-with-nemluvio-nemolizumab-for-up-to-three-years-in-patients-with-moderate-to-severe-atopic-dermatitis","published":"2026-09-30T05:04:00Z","seen":"2026-09-30T07:14:32Z","lang":"en","source":{"id":"thewhig.com","name":"thewhig.com","domain":"thewhig.com","outlet":{"wikidata":"Q928635","name":"Kingston Whig-Standard","type":"newspaper","country":"CA","designations":["daily newspaper"]}},"via":"gdelt-gkg-english","topics":["economy","education","health","politics"],"authors":["Business Wire"],"entities":[{"id":"Q581008","name":"Galderma","type":"org"},{"id":"Q30314619","name":"nemolizumab","type":"other"},{"id":"Q268667","name":"atopic dermatitis","type":"other"}],"story":"st_5srwxlcatjcqhidujepq","category":"health","category_p":0.6,"sentiment":"positive","tone":0.14,"political":0.02}]}